Travere Therapeutics Inc (TVTX) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Travere Therapeutics Inc   (NASDAQ: TVTX)
 

Travere Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Travere Therapeutics Inc 's inventory turnover ratio sequentially decreased to 0.4 in the third quarter 2026, unsurprisingly, as the Travere Therapeutics Inc markets continue to deteriorate, and TVTX's faces growing challenges to bring down its inventories. Travere Therapeutics Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 913 days, from 640 days, in the Jun 30 2026 quarter.

Within Healthcare sector 359 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1198 in the second quarter 2026, to 1730.

TVTX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Travere Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TVTX Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 689.53 % 879.19 % 61.65 % -85.96 % -12.71 %
Y / Y Cost of Sales Growth 80.88 % 42.93 % -58.32 % 0.04 % -2.52 %
Inventory Turnover Ratio (TTM) 0.4 0.57 1.39 2.13 0.75
TVTX's Total Ranking # 1730 # 1198 # 1062 # 1291 #
Average inventory processing period 919 639 262 172 489
Seq. Inventory Growth 9.37 % 530.1 % 8.19 % 5.89 % 35.65 %
Seq. Cost of Sales Growth 31.88 % 11.49 % -23.65 % 61.14 % 4.21 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 114
Healthcare Sector # 360
Overall Market # 1730

Inventory Turnover Ratio Statistics
High Average Low
3.85 1.1 0.4
(Dec 31 2014)   (Sep 30 2026)



TVTX Company Profile >> Back to TVTX Efficiency Comparisons >> Compare TVTX Inventory Turnover Ratio to its Competitors

Financial Statements
Travere Therapeutics Inc 's Inventories $ 44 Millions Visit TVTX's Balance sheet
Travere Therapeutics Inc 's Cost of Revenues TTM $ 10 Millions Visit TVTX's Income Statement
What are TVTX's Sales? Visit TVTX's Sales by Segment

Other Inventory Turnover Ratios
Travere Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TVTX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TVTX's Competitors
Inventory Turnover Ratio for TVTX's Suppliers
Inventory Turnover Ratio for TVTX's Customers

You may also want to know
TVTX's Sales Growth Rates TVTX's Pe Price to earnings ratio TVTX's Receivables Turnover Ratio TVTX's Stock Quote
TVTX's Net Income Growth Rates TVTX's Ps Price to Sales ratio TVTX's Sales per Employee TVTX's Asset Turnover Ratio
TVTX's Net Margin TVTX's Pb Price to Book ratio TVTX's Financial Strength Ratios TVTX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Lenz Therapeutics Inc   0.58 $ 2.228  Millions$ 4  Millions
Lexicon Pharmaceuticals Inc   0.58 $ 0.427  Millions$ 1  Millions
Biomarin Pharmaceutical Inc  0.57 $ 878.919  Millions$ 1,538  Millions
Orchestra Biomed Holdings Inc   0.51 $ 0.136  Millions$ 0  Millions
Liquidia Corporation  0.51 $ 15.886  Millions$ 31  Millions
Verastem Inc   0.51 $ 1.117  Millions$ 2  Millions
Orthopediatrics Corp  0.50 $ 68.827  Millions$ 137  Millions
Heron Therapeutics Inc   0.47 $ 43.530  Millions$ 92  Millions
Kura Oncology Inc   0.40 $ 0.876  Millions$ 2  Millions
Travere Therapeutics Inc   0.40 $ 9.545  Millions$ 24  Millions
Ionis Pharmaceuticals Inc   0.38 $ 9.044  Millions$ 24  Millions
Ardelyx inc   0.31 $ 25.958  Millions$ 84  Millions
Yubo International Biotech Limited  0.18 $ 0.004  Millions$ 0  Millions
Dermata Therapeutics Inc   0.11 $ 0.034  Millions$ 0  Millions
Madrigal Pharmaceuticals Inc   0.10 $ 10.400  Millions$ 102  Millions

Date modified: 2026-11-03T16:39:47+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.